BILLERICA, Mass., Nov. 1, 2012 /PRNewswire/ -- SRS Medical announces the acquisition of The Spanner Temporary Prostatic Stent from AbbeyMoor Medical of Parkers Prairie, MN. The Spanner is FDA cleared, CE-marked, has a dedicated CPT code and is protected by patents worldwide. SRS is manufacturing The Spanner in the United States and distributing it worldwide through a hybrid distribution model of employed and brokerage representation.
"The Spanner is a synergistic addition to our suite of urology products for the diagnosis and treatment of men with symptoms of bladder outlet obstruction," said Lee Brody, CEO of SRS Medical. "Along with our flagship CT3000 UroCuff exam, SRS continues to provide the urologist innovative tools for diagnosis and treatment in the office setting."
The Spanner is placed in the prostatic urethra and opens the urethra as it passes through the prostate. Once fitted, the patient is able to fill and empty his bladder normally while significantly reducing post void residual. The Spanner stent can be an alternative to an indwelling Foley catheter and in a comparative clinical trial, incidence of bacterial colonization was significantly reduced.
"In a prior trial, The Spanner demonstrated a statistically significant reduction in the rate of bacterial colonization in comparison to an indwelling Foley catheter, which may have benefit toward reducing clinically significant urinary tract infections. The avoidance of an external catheter and the attendant drainage bag should also result in quality of life benefit when using The Spanner," said Dr. Neal D. Shore, M.D., FACS, Medical Director of the Carolina Urologic Research Center.
The Spanner is designed for clinical efficacy and ease in administration for both the patient and clinician. The stent can be inserted or removed in the physician office without anesthesia or cystoscopy. For the patient, The Spanner has no care or maintenance requirement, unlike an indwelling Foley catheter. Clinical studies have shown the stent safely improves urine flow rates and decreases the amount of urine left in the bladder. Published data further shows that the stent is well tolerated by patients and is preferred to a urethral catheter.
For more information, visit www.thespanner.com
Background on SRS Medical
SRS Medical is a privately held Delaware corporation that manufactures and distributes proprietary products for the diagnosis and treatment of voiding dysfunction. The company's mission is to provide unique diagnostic and treatment solutions to the clinical community that combine diagnostic clarity and ease of administration to improve patient care. To learn more about SRS Medical and its products, please visit www.srsmedical.com.
David Mahoney, Vice President Sales & Marketing
Mail to: firstname.lastname@example.org
SOURCE SRS Medical